Datasets:

electricsheepafrica
/

malaria-rdt-act-commodity

id int64	facility_level string	facility_id string	region_type string	malaria_endemicity string	pmi_supported int64	has_microscopy int64	lmis_type string	commodity_name string	commodity_category string	target_age_group string	pack_size int64	unit_cost_usd float64	year int64	month int64	transmission_season int64	suspected_malaria_cases int64	confirmed_malaria_cases int64	severe_malaria_cases int64	available_on_survey_day int64	stocked_out_in_last_6m int64	stockout_days_last_6m int64	stockout_during_peak_season int64	stockout_cause string	test_before_treat_rate float64	patients_tested int64	presumptive_treatment int64	act_courses_dispensed int64	months_of_stock float64	last_resupply_days_ago int64	order_fill_rate_pct float64	patients_untreated_no_act int64	referred_for_severe_malaria int64	malaria_deaths int64	report_submitted int64	report_timely int64
1	health_centre	MAL_0023	rural	mesoendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,021	10	1	66	29	4	1	0	0	0	not_applicable	0.43	28	38	30	1.7	43	47.8	0	0	2	0	0
2	health_centre	MAL_0169	peri_urban	hyperendemic	1	1	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,022	10	1	61	30	2	1	1	5	1	demand_surge_epidemic	0.64	39	22	29	1	47	59.8	0	0	0	0	0
3	health_centre	MAL_0159	peri_urban	holoendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,023	2	0	28	13	1	1	0	0	0	not_applicable	0.67	18	10	3	1.4	73	66.8	0	0	0	1	1
4	health_centre	MAL_0087	peri_urban	hyperendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,022	6	1	33	18	3	1	0	0	0	not_applicable	0.47	15	18	14	1.3	60	65.3	0	0	0	1	1
5	health_centre	MAL_0124	rural	hyperendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,023	9	1	50	19	3	0	0	0	0	not_applicable	0.64	0	50	0	0.7	13	43.7	10	1	0	1	0
6	health_centre	MAL_0137	rural	mesoendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,023	3	0	27	14	0	1	1	16	1	PMI_shipment_delay	0.73	19	8	6	1	52	52.2	0	0	0	1	0
7	health_centre	MAL_0074	rural	hyperendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,021	1	0	25	14	1	1	1	8	1	national_stockout	0.68	17	8	13	1.6	119	32.9	0	0	0	1	0
8	health_centre	MAL_0182	rural	holoendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,022	9	1	50	32	3	0	0	0	0	not_applicable	0.6	0	50	0	1.3	39	38.8	0	1	1	0	0
9	health_centre	MAL_0056	rural	hyperendemic	1	0	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,023	11	1	50	36	3	0	1	2	1	funding_gap	0.72	0	50	0	0.7	15	52.1	0	1	0	1	1
10	health_centre	MAL_0070	rural	holoendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,023	2	0	26	13	2	1	0	0	0	not_applicable	0.49	12	14	10	3	44	78.1	0	0	0	0	0
11	health_centre	MAL_0125	rural	hyperendemic	1	0	paper	RDT_Pf_Pan	diagnostic	all_ages	25	0.55	2,021	1	0	24	18	4	1	0	0	0	not_applicable	0.47	11	13	5	1.6	86	50.1	0	0	0	1	0
12	health_centre	MAL_0240	rural	holoendemic	1	0	paper	SP_tablet	IPTp	pregnant_women	3	0.05	2,024	11	1	66	27	1	0	1	1	0	PMI_shipment_delay	0.5	0	66	0	1.6	17	54.4	0	0	0	1	0
13	health_centre	MAL_0129	peri_urban	hyperendemic	1	0	paper	LLIN_standard	prevention	household	1	3.5	2,024	9	1	68	36	3	1	1	1	0	national_stockout	0.61	41	27	23	2.9	38	41.3	0	0	1	0	0
14	health_centre	MAL_0157	rural	holoendemic	1	0	paper	LLIN_PBO	prevention	household	1	5	2,023	8	1	68	35	2	1	1	1	1	quantification_seasonal_error	0.51	34	34	31	0.5	13	77.5	0	0	1	1	1
15	health_centre	MAL_0115	rural	mesoendemic	1	0	paper	primaquine_15mg	radical_cure	adult_Pv	14	0.1	2,023	7	1	59	39	3	0	1	43	1	quality_rejection	0.54	0	59	0	0.4	20	80.7	0	1	2	0	0
16	health_centre	MAL_0023	rural	holoendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,022	4	0	26	7	0	0	0	0	0	not_applicable	0.74	0	26	0	0	23	66.9	2	0	0	1	0
17	health_centre	MAL_0182	rural	mesoendemic	1	0	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,024	6	1	63	28	1	1	0	0	0	not_applicable	0.42	26	37	24	3.6	47	45.7	0	0	0	1	1
18	health_centre	MAL_0163	rural	hypoendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,024	12	0	27	20	1	1	0	0	0	not_applicable	0.4	10	17	9	0.8	2	65.9	0	0	0	1	0
19	health_centre	MAL_0011	peri_urban	mesoendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,024	11	1	59	37	1	1	1	38	1	funding_gap	0.61	35	24	31	1.7	5	28.1	0	0	0	1	0
20	health_centre	MAL_0061	rural	hypoendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,023	1	0	31	14	0	1	0	0	0	not_applicable	0.56	17	14	8	1.1	38	44.7	0	0	0	1	0
21	health_centre	MAL_0131	rural	holoendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,021	12	0	32	21	0	1	0	0	0	not_applicable	0.47	15	17	21	1.6	54	63.4	0	0	0	0	0
22	health_centre	MAL_0135	rural	mesoendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,024	4	0	19	11	1	1	1	6	1	demand_surge_epidemic	0.55	10	9	11	0.8	19	26.9	0	0	0	1	0
23	health_centre	MAL_0119	peri_urban	hyperendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,024	6	1	59	36	4	0	0	0	0	not_applicable	0.56	0	59	0	2.5	15	55.4	0	1	1	0	0
24	health_centre	MAL_0096	urban	holoendemic	1	0	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,021	6	1	48	24	2	0	0	0	0	not_applicable	0.71	0	48	0	2.9	79	35.5	0	0	2	0	0
25	health_centre	MAL_0112	peri_urban	mesoendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,022	10	1	59	38	2	0	0	0	0	not_applicable	0.43	0	59	0	0.7	12	79.1	0	0	0	0	0
26	health_centre	MAL_0011	rural	holoendemic	1	0	paper	RDT_Pf_Pan	diagnostic	all_ages	25	0.55	2,024	6	1	28	17	2	1	1	58	0	demand_surge_epidemic	0.52	14	14	14	2	8	68.6	0	0	0	0	0
27	health_centre	MAL_0083	rural	mesoendemic	1	0	paper	SP_tablet	IPTp	pregnant_women	3	0.05	2,024	6	1	57	22	2	1	0	0	0	not_applicable	0.56	31	26	15	2.9	20	55.6	0	0	1	1	1
28	health_centre	MAL_0036	urban	holoendemic	1	0	paper	LLIN_standard	prevention	household	1	3.5	2,023	8	1	55	32	4	0	1	15	0	quality_rejection	0.4	0	55	0	2.1	51	33.2	0	1	2	1	0
29	health_centre	MAL_0215	rural	hyperendemic	1	0	paper	LLIN_PBO	prevention	household	1	5	2,021	6	1	57	35	1	1	1	1	0	expired_stock	0.6	34	23	27	0.3	32	61.6	0	0	0	0	0
30	health_centre	MAL_0059	urban	hyperendemic	1	0	paper	primaquine_15mg	radical_cure	adult_Pv	14	0.1	2,021	11	1	50	35	3	1	0	0	0	not_applicable	0.51	25	25	30	1.6	37	66.7	0	0	0	0	0
31	health_centre	MAL_0106	rural	holoendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,021	10	1	61	34	2	1	1	3	1	district_distribution_delay	0.57	34	27	36	1.4	54	57.7	0	0	0	1	0
32	health_centre	MAL_0097	peri_urban	hypoendemic	1	0	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,024	3	0	26	12	0	1	1	19	1	district_distribution_delay	0.6	15	11	9	2.8	45	76.8	0	0	0	0	0
33	health_centre	MAL_0064	rural	mesoendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,023	10	1	37	18	1	1	0	0	0	not_applicable	0.45	16	21	12	0	1	44.3	0	0	0	1	1
34	health_centre	MAL_0213	peri_urban	holoendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,022	2	0	22	13	0	1	0	0	0	not_applicable	0.55	12	10	10	0.3	10	68.3	0	0	0	0	0
35	health_centre	MAL_0117	peri_urban	hyperendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,023	11	1	61	35	1	1	0	0	0	not_applicable	0.56	34	27	34	1.6	54	60.4	0	0	0	1	1
36	health_centre	MAL_0176	peri_urban	hyperendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,024	8	1	59	29	3	0	0	0	0	not_applicable	0.69	0	59	0	0.7	20	67.6	5	2	1	1	1
37	health_centre	MAL_0215	peri_urban	holoendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,024	1	0	28	19	2	1	0	0	0	not_applicable	0.6	16	12	17	0.2	1	56.8	0	0	2	1	1
38	health_centre	MAL_0143	rural	hyperendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,022	11	1	48	16	0	0	1	3	1	demand_surge_epidemic	0.42	0	48	0	2.2	41	77.3	0	0	0	1	0
39	health_centre	MAL_0179	rural	hyperendemic	1	1	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,024	12	0	25	11	1	0	1	25	1	global_fund_delay	0.41	10	15	0	0	65	58.4	0	0	0	0	0
40	health_centre	MAL_0163	rural	hyperendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,024	9	1	68	34	2	0	1	6	0	quantification_seasonal_error	0.59	0	68	0	5.6	6	47.4	0	1	2	1	1
41	health_centre	MAL_0085	peri_urban	holoendemic	1	0	paper	RDT_Pf_Pan	diagnostic	all_ages	25	0.55	2,023	5	0	21	11	1	1	1	8	1	global_fund_delay	0.58	12	9	4	2.7	198	29.6	0	0	0	1	1
42	health_centre	MAL_0078	rural	hypoendemic	1	0	paper	SP_tablet	IPTp	pregnant_women	3	0.05	2,024	10	1	79	46	2	0	0	0	0	not_applicable	0.48	0	79	0	1.3	27	53.3	0	1	1	0	0
43	health_centre	MAL_0185	peri_urban	hyperendemic	1	0	paper	LLIN_standard	prevention	household	1	3.5	2,024	4	0	17	7	0	1	1	5	0	facility_ordering_late	0.72	12	5	8	3.4	44	53.2	0	0	0	0	0
44	health_centre	MAL_0019	rural	hyperendemic	1	0	paper	LLIN_PBO	prevention	household	1	5	2,023	11	1	55	30	2	0	1	10	1	global_fund_delay	0.66	0	55	0	2.8	87	71.3	0	1	0	1	0
45	health_centre	MAL_0165	rural	mesoendemic	1	0	paper	primaquine_15mg	radical_cure	adult_Pv	14	0.1	2,023	3	0	23	16	4	0	1	24	1	theft_diversion	0.52	0	23	0	0.9	17	58.5	0	1	1	1	0
46	health_centre	MAL_0162	rural	hyperendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,023	4	0	25	9	0	0	0	0	0	not_applicable	0.63	0	25	0	0.1	106	53.5	15	0	0	1	0
47	health_centre	MAL_0178	rural	hyperendemic	1	0	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,024	5	0	25	16	1	1	1	19	1	demand_surge_epidemic	0.51	12	13	18	2.3	17	79.6	0	0	0	0	0
48	health_centre	MAL_0188	rural	holoendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,021	3	0	22	12	0	1	0	0	0	not_applicable	0.51	11	11	0	1.8	49	73.7	0	0	0	0	0
49	health_centre	MAL_0130	rural	holoendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,024	5	0	27	17	2	1	0	0	0	not_applicable	0.46	12	15	11	1.2	35	43.7	0	0	1	0	0
50	health_centre	MAL_0249	rural	hyperendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,022	10	1	59	33	2	0	0	0	0	not_applicable	0.47	0	59	0	1.7	17	64.8	8	0	1	1	1
51	health_centre	MAL_0113	peri_urban	holoendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,023	12	0	16	9	0	0	0	0	0	not_applicable	0.38	0	16	0	0	2	53.8	2	0	0	1	0
52	health_centre	MAL_0199	rural	hypoendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,021	8	1	48	29	0	0	1	7	0	facility_ordering_late	0.71	0	48	0	2.8	48	53.9	1	0	0	0	0
53	health_centre	MAL_0067	rural	holoendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,023	2	0	15	8	0	0	1	16	0	PMI_shipment_delay	0.52	0	15	0	0	42	54.1	0	0	0	0	0
54	health_centre	MAL_0011	peri_urban	mesoendemic	1	0	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,024	2	0	25	18	1	1	0	0	0	not_applicable	0.63	15	10	18	1.3	12	73.5	0	0	0	0	0
55	health_centre	MAL_0213	rural	hyperendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,024	2	0	20	10	0	0	0	0	0	not_applicable	0.45	0	20	0	4.7	86	51.8	0	0	0	1	0
56	health_centre	MAL_0093	peri_urban	hyperendemic	1	0	paper	RDT_Pf_Pan	diagnostic	all_ages	25	0.55	2,024	6	1	57	33	3	1	1	9	0	demand_surge_epidemic	0.62	35	22	28	3.6	17	54.2	0	0	0	1	0
57	health_centre	MAL_0116	rural	holoendemic	1	0	paper	SP_tablet	IPTp	pregnant_women	3	0.05	2,022	3	0	24	12	1	1	1	7	1	demand_surge_epidemic	0.49	11	13	9	0.9	3	37.3	0	0	0	0	0
58	health_centre	MAL_0102	rural	mesoendemic	1	0	paper	LLIN_standard	prevention	household	1	3.5	2,023	2	0	23	11	2	0	0	0	0	not_applicable	0.56	0	23	0	2.2	46	58.4	0	1	0	1	0
59	health_centre	MAL_0008	peri_urban	hyperendemic	1	0	paper	LLIN_PBO	prevention	household	1	5	2,023	8	1	50	33	4	1	1	5	1	expired_stock	0.56	28	22	33	1.3	59	56.3	0	0	1	0	0
60	health_centre	MAL_0046	rural	holoendemic	1	0	paper	primaquine_15mg	radical_cure	adult_Pv	14	0.1	2,022	8	1	74	40	0	0	0	0	0	not_applicable	0.52	0	74	0	3.2	78	27.8	0	0	0	1	1
61	health_centre	MAL_0142	peri_urban	mesoendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,023	10	1	46	23	5	0	0	0	0	not_applicable	0.3	0	46	0	2.5	46	54.2	2	0	1	1	0
62	health_centre	MAL_0056	peri_urban	hyperendemic	1	0	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,021	11	1	55	38	2	0	1	2	1	global_fund_delay	0.54	0	55	0	2.7	19	41.9	14	1	1	0	0
63	health_centre	MAL_0062	rural	mesoendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,023	1	0	24	11	2	0	1	57	1	quality_rejection	0.39	0	24	0	2.2	37	65	1	0	1	1	0
64	health_centre	MAL_0247	rural	hyperendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,022	1	0	38	26	5	0	0	0	0	not_applicable	0.57	0	38	0	2.1	40	76.4	18	2	1	1	1
65	health_centre	MAL_0029	urban	mesoendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,024	2	0	27	16	0	0	1	6	0	theft_diversion	0.69	0	27	0	1.4	3	50.6	1	0	0	1	0
66	health_centre	MAL_0065	rural	holoendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,023	7	1	50	40	5	1	0	0	0	not_applicable	0.44	22	28	40	2.9	25	69.2	0	0	2	1	1
67	health_centre	MAL_0147	rural	hyperendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,024	6	1	55	25	0	0	1	48	1	theft_diversion	0.73	0	55	0	1.4	62	53.1	0	0	0	0	0
68	health_centre	MAL_0187	rural	hyperendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,023	10	1	50	33	4	0	1	3	0	PMI_shipment_delay	0.69	0	50	0	1.8	67	55.1	0	1	0	0	0
69	health_centre	MAL_0200	peri_urban	holoendemic	1	0	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,024	2	0	29	13	1	1	1	7	1	district_distribution_delay	0.42	12	17	9	0.5	28	40.7	0	0	0	1	0
70	health_centre	MAL_0069	peri_urban	holoendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,022	3	0	21	16	0	1	1	17	1	global_fund_delay	0.58	12	9	10	3.4	19	29	0	0	0	0	0
71	health_centre	MAL_0118	rural	hypoendemic	1	0	paper	RDT_Pf_Pan	diagnostic	all_ages	25	0.55	2,023	8	1	35	10	1	0	0	0	0	not_applicable	0.41	0	35	0	4.2	31	69.2	0	0	1	0	0
72	health_centre	MAL_0030	peri_urban	hyperendemic	1	0	paper	SP_tablet	IPTp	pregnant_women	3	0.05	2,023	11	1	77	34	1	1	1	64	1	facility_ordering_late	0.47	36	41	26	2.7	11	55.8	0	0	1	1	0
73	health_centre	MAL_0249	peri_urban	holoendemic	1	0	paper	LLIN_standard	prevention	household	1	3.5	2,022	10	1	52	28	4	1	0	0	0	not_applicable	0.28	14	38	26	3.2	24	66.3	0	0	0	1	0
74	health_centre	MAL_0039	peri_urban	holoendemic	1	0	paper	LLIN_PBO	prevention	household	1	5	2,023	5	0	31	14	2	0	1	18	0	national_stockout	0.7	0	31	0	0.1	13	78.4	0	1	1	0	0
75	health_centre	MAL_0135	peri_urban	holoendemic	1	0	paper	primaquine_15mg	radical_cure	adult_Pv	14	0.1	2,021	10	1	77	69	3	0	0	0	0	not_applicable	0.69	0	77	0	2	32	22.8	0	2	0	0	0
76	health_centre	MAL_0135	rural	mesoendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,024	4	0	35	23	5	1	1	10	1	district_distribution_delay	0.53	18	17	17	1.2	2	66	0	0	1	1	1
77	health_centre	MAL_0084	rural	mesoendemic	1	0	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,024	10	1	50	38	2	0	1	81	1	theft_diversion	0.57	0	50	0	2.3	115	33.8	0	1	1	1	1
78	health_centre	MAL_0229	rural	hyperendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,022	9	1	68	36	1	0	1	11	0	funding_gap	0.4	0	68	0	2.3	141	93.6	1	0	1	0	0
79	health_centre	MAL_0027	rural	hyperendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,023	8	1	59	31	3	0	0	0	0	not_applicable	0.48	0	59	0	1.2	11	37.9	0	0	0	0	0
80	health_centre	MAL_0022	urban	mesoendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,024	1	0	27	14	2	1	0	0	0	not_applicable	0.53	14	13	8	1.9	25	80.2	0	0	1	1	0
81	health_centre	MAL_0161	urban	mesoendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,022	11	1	48	32	4	0	0	0	0	not_applicable	0.47	0	48	0	0.5	38	55.8	2	2	1	0	0
82	health_centre	MAL_0192	rural	hyperendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,023	3	0	25	14	1	1	0	0	0	not_applicable	0.65	16	9	13	0	208	68.3	0	0	0	0	0
83	health_centre	MAL_0128	peri_urban	holoendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,021	6	1	52	17	0	0	1	22	1	demand_surge_epidemic	0.6	0	52	0	1.4	33	59.4	0	0	0	1	0
84	health_centre	MAL_0236	rural	mesoendemic	1	0	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,022	7	1	48	27	7	0	0	0	0	not_applicable	0.63	0	48	0	2.8	110	44.9	0	3	3	1	1
85	health_centre	MAL_0159	rural	hyperendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,023	7	1	63	30	1	0	1	6	0	district_distribution_delay	0.5	0	63	0	2.6	14	61.5	0	0	0	1	0
86	health_centre	MAL_0201	rural	holoendemic	1	0	paper	RDT_Pf_Pan	diagnostic	all_ages	25	0.55	2,023	1	0	24	16	1	1	0	0	0	not_applicable	0.51	12	12	15	2.8	119	48.8	0	0	0	0	0
87	health_centre	MAL_0217	peri_urban	hyperendemic	1	0	paper	SP_tablet	IPTp	pregnant_women	3	0.05	2,022	6	1	28	13	0	1	0	0	0	not_applicable	0.42	11	17	12	0	68	73.4	0	0	0	1	0
88	health_centre	MAL_0174	urban	holoendemic	1	0	paper	LLIN_standard	prevention	household	1	3.5	2,023	3	0	20	9	0	0	1	30	0	national_stockout	0.57	0	20	0	1.2	101	46.3	0	0	0	1	1
89	health_centre	MAL_0017	rural	hyperendemic	1	0	paper	LLIN_PBO	prevention	household	1	5	2,023	11	1	41	17	3	1	0	0	0	not_applicable	0.43	17	24	19	2.7	6	51.9	0	0	1	0	0
90	health_centre	MAL_0025	rural	hyperendemic	1	0	paper	primaquine_15mg	radical_cure	adult_Pv	14	0.1	2,022	3	0	21	6	0	1	0	0	0	not_applicable	0.44	9	12	1	4.2	51	61.7	0	0	0	1	0
91	health_centre	MAL_0183	rural	hyperendemic	1	0	paper	AL_6x1_infant	ACT	infant_5_14kg	6	0.3	2,023	7	1	55	28	1	1	1	10	1	district_distribution_delay	0.51	28	27	25	3.8	18	69.5	0	0	0	1	1
92	health_centre	MAL_0084	peri_urban	mesoendemic	1	0	paper	AL_6x2_child	ACT	child_15_24kg	12	0.45	2,023	6	1	57	32	2	0	0	0	0	not_applicable	0.58	0	57	0	3	45	63.9	0	0	2	0	0
93	health_centre	MAL_0184	rural	hyperendemic	1	0	paper	AL_6x3_adolescent	ACT	adolescent_25_34kg	18	0.55	2,022	1	0	24	15	2	1	1	9	1	district_distribution_delay	0.47	11	13	16	2.4	30	46.2	0	0	0	1	0
94	health_centre	MAL_0041	peri_urban	mesoendemic	1	0	paper	AL_6x4_adult	ACT	adult_35kg_plus	24	0.65	2,023	6	1	48	27	2	0	1	1	1	expired_stock	0.46	0	48	0	0.1	67	67.9	1	1	0	1	0
95	health_centre	MAL_0138	peri_urban	mesoendemic	1	0	paper	ASAQ_infant	ACT	infant_5_14kg	3	0.4	2,024	2	0	35	16	2	1	0	0	0	not_applicable	0.51	17	18	13	3	1	66	0	0	0	1	1
96	health_centre	MAL_0190	peri_urban	holoendemic	1	0	paper	ASAQ_child	ACT	child_15_24kg	3	0.5	2,022	3	0	23	6	0	1	1	8	0	theft_diversion	0.64	14	9	4	1.2	15	65	0	0	0	0	0
97	health_centre	MAL_0183	rural	hyperendemic	1	0	paper	ASAQ_adult	ACT	adult_35kg_plus	3	0.7	2,024	11	1	48	15	2	0	1	10	0	demand_surge_epidemic	0.42	0	48	0	0.8	16	63.9	0	1	0	1	0
98	health_centre	MAL_0013	peri_urban	mesoendemic	1	0	paper	artesunate_60mg_inj	severe_malaria	all_ages	1	1	2,022	11	1	55	30	1	0	0	0	0	not_applicable	0.6	0	55	0	3.1	4	93.1	0	0	1	0	0
99	health_centre	MAL_0042	rural	holoendemic	1	0	paper	artesunate_rectal_100mg	pre_referral	child_under5	1	0.5	2,023	2	0	18	8	0	0	0	0	0	not_applicable	0.51	0	18	0	2	19	69	0	0	0	1	0
100	health_centre	MAL_0066	peri_urban	hyperendemic	1	0	paper	RDT_Pf_only	diagnostic	all_ages	25	0.4	2,024	11	1	52	22	5	1	0	0	0	not_applicable	0.46	23	29	16	0.8	74	53.5	0	0	0	0	0

End of preview. Expand in Data Studio

Malaria RDT & ACT Commodity Dataset

Abstract

This dataset provides 30,000 simulated facility-level observations (10,000 per scenario) of malaria rapid diagnostic test (RDT) and artemisinin-based combination therapy (ACT) commodity availability across three tiers of malaria case management in sub-Saharan Africa. Each record represents one malaria commodity assessed at one facility during one monthly period, capturing 40+ variables including commodity type, seasonal demand dynamics, day-of-survey availability, stockout metrics, test-before-treat rates, presumptive treatment, and malaria mortality. Three scenarios model the case management gradient: PMI-supported district hospital (79% availability), health centre (53%), and community iCCM (29%).

This dataset is entirely simulated. It must not be used for clinical or programme decisions.

1. Introduction

1.1 The Malaria Commodity Challenge

Malaria remains the leading cause of morbidity and mortality in sub-Saharan Africa, with an estimated 233 million cases and 580,000 deaths in 2022 (WHO World Malaria Report). Effective case management depends on two commodities: rapid diagnostic tests (RDTs) for parasitological confirmation and artemisinin-based combination therapies (ACTs) for treatment. The WHO "test-before-treat" policy requires that all suspected malaria cases receive a parasitological test before treatment, yet commodity stockouts at the facility level frequently undermine this strategy.

1.2 ACT Supply and Availability

Between 2010 and 2023, approximately 4.5 billion treatment courses of prequalified ACTs were delivered globally by manufacturers, with an estimated 68% distributed to the public sector in malaria-endemic countries (WHO, 2023). Multi-country surveys documented ACT stockout rates of 2% in Ghana to 7% in Kenya at facility level, with higher rates at peripheral facilities (PMC, 2014; PMC4263677). An estimated 50% of suspected malaria cases in SSA first seek care in the private sector, where quality-assured ACT availability and pricing remain problematic (Malaria Journal, 2024).

1.3 RDT Stockouts and Presumptive Treatment

RDT stockouts are a major constraint on malaria case management quality. In Niger State, Nigeria, a study found that 77% of fever cases were tested with RDTs at supported facilities, with 53% confirmed as malaria — but stockouts of RDTs were the primary barrier, and severe fever cases triggered presumptive treatment in the absence of diagnostic confirmation (PMC, 2016; PMC4799818). Presumptive treatment drives overuse of ACTs, wastes limited commodity stocks, and exposes non-malaria patients to unnecessary antimalarial therapy.

1.4 Seasonal Demand Surges

Malaria transmission is highly seasonal in the Sahel and East African highlands, with 2-3 fold increases in case volume during rainy seasons. Supply chains that fail to anticipate seasonal demand surges experience acute stockouts precisely when commodities are most needed. The mismatch between fixed quarterly resupply schedules and variable seasonal demand is a persistent quantification challenge (Unitaid forecasting methodology).

1.5 Rationale

This dataset integrates malaria commodity availability, seasonal demand patterns, testing practices, and patient outcomes into a single analytical resource for supply chain modelling, seasonal quantification research, and test-before-treat policy analysis.

2. Methodology

2.1 Parameterization

Parameter	PMI Hospital	Health Centre	Community iCCM	Source
ACT availability	88%	65%	40%	PMC4263677: 2-7% stockout
RDT availability	85%	60%	35%	PMC4799818: stockouts major constraint
Injectable artesunate	75%	30%	2%	Severe malaria management
Seasonal surge factor	1.8x	2.2x	2.8x	Unitaid methodology
Stockout in 6m	25%	50%	77%	Multi-country data
Test-before-treat	85%	55%	30%	WHO target 100%
Order fill rate	81%	58%	30%	PMI end-use verification

2.2 Commodity Selection

15 malaria commodities across 6 categories:

Category	Commodities
ACT (age-weight bands)	AL 6x1 infant, AL 6x2 child, AL 6x3 adolescent, AL 6x4 adult, ASAQ infant/child/adult
Severe malaria	Artesunate 60mg injection
Pre-referral	Artesunate rectal 100mg
Diagnostics	RDT Pf-only, RDT Pf/Pan
IPTp	Sulfadoxine-pyrimethamine
Prevention	LLIN standard, LLIN PBO
Radical cure	Primaquine 15mg

2.3 Scenario Design

Scenario A — PMI-Supported District Hospital: Laboratory with microscopy, electronic LMIS, dedicated malaria focal person, PMI/Global Fund supply, year-round case management. Analogous to district hospitals in Nigeria, DRC, Mozambique.

Scenario B — Health Centre: Nurse-led, RDT-based diagnosis only, paper LMIS, quarterly resupply, high seasonal variation. Analogous to health centres in Uganda, Malawi, Tanzania, Burkina Faso.

Scenario C — Community iCCM: CHW-delivered integrated community case management, RDT + ACT only, no injectable artesunate, resupply from parent health centre. Analogous to iCCM programmes in Niger, Sierra Leone, DRC, Zambia.

3. Schema

Column	Type	Description
facility_level	categorical	Facility tier
malaria_endemicity	categorical	holoendemic / hyperendemic / mesoendemic / hypoendemic
commodity_name	categorical	15 malaria commodities
commodity_category	categorical	ACT / diagnostic / severe_malaria / pre_referral / IPTp / prevention / radical_cure
target_age_group	categorical	Age-weight band
transmission_season	binary	Peak transmission month
suspected_malaria_cases	int	Monthly suspected cases
confirmed_malaria_cases	int	Parasitologically confirmed
severe_malaria_cases	int	Severe malaria cases
available_on_survey_day	binary	Commodity available
stocked_out_in_last_6m	binary	Any stockout in 6 months
stockout_days_last_6m	int	Total stockout days
stockout_during_peak_season	binary	Stockout coincided with peak
stockout_cause	categorical	11 root cause categories
test_before_treat_rate	float	Proportion tested before treatment
patients_tested	int	Patients tested with RDT/microscopy
presumptive_treatment	int	Patients treated without test
act_courses_dispensed	int	ACT courses given
months_of_stock	float	Current stock in months
order_fill_rate_pct	float	Order fulfilment rate
patients_untreated_no_act	int	Patients not treated due to stockout
referred_for_severe_malaria	int	Severe cases referred
malaria_deaths	int	Deaths from malaria

4. Validation

Validation Report

4.1 Key Results

Metric	PMI Hospital	Health Centre	Community	Literature
Availability	79%	53%	29%	2-7% stockout at hospital [2]
Stocked out 6m	25%	50%	77%	Multi-country data
Test-before-treat	84%	55%	30%	WHO target 100% [1]
Order fill rate	81%	58%	30%	PMI data

5. Usage

from datasets import load_dataset

dataset = load_dataset(
    "electricsheepafrica/malaria-rdt-act-commodity",
    "health_centre"
)
df = dataset["train"].to_pandas()

# Seasonal stockout analysis
seasonal = df.groupby('transmission_season').agg({
    'available_on_survey_day': 'mean',
    'presumptive_treatment': 'mean'
})
print(seasonal)

6. Limitations

Simulated: Not from real PMI or Global Fund supply chain data.
Simplified seasonality: Binary peak/off-peak rather than continuous transmission intensity.
No drug resistance modelling: ACT efficacy is assumed constant.
No private sector: Focus on public/community sector only.

7. References

PMC (2016). Improving access to malaria RDT in Niger State, Nigeria. 77% tested; RDT stockouts major constraint. PMC4799818.
PMC (2014). Pharmaceutical availability: Ghana ACT stockout 2%, Kenya 7%. PMC4263677.
WHO (2023). Artemisinin partial resistance. 4.5 billion ACT courses 2010-2023.
Malaria Journal (2024). Assessing availability of quality-assured ACTs. ~50% seek care in private sector.
Unitaid. Forecasting methodology for global malaria diagnostic and ACT demand.
PMI / USAID. End-use verification surveys.

Citation

@dataset{esa_malaria_rdt_act_2025,
  title   = {Malaria RDT and ACT Commodity Dataset: Availability,
             Seasonal Demand, Test-Before-Treat, and Patient Impact
             Across Three Tiers of Malaria Case Management in SSA},
  author  = {{Electric Sheep Africa}},
  year    = {2025},
  publisher = {Hugging Face},
  url     = {https://huggingface.co/datasets/electricsheepafrica/malaria-rdt-act-commodity},
  note    = {Simulated dataset. Not for clinical or programme decisions.}
}

License

CC-BY-4.0

Downloads last month: 28

Size of downloaded dataset files:

5.4 MB

Size of the auto-converted Parquet files:

1.05 MB

Number of rows:

30,000